Pharsight

Halflytely patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7291324 BRAINTREE Method of bowel cleansing
Oct, 2022

(1 year, 4 months ago)

Halflytely is owned by Braintree.

Halflytely contains Bisacodyl; Polyethylene Glycol 3350; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride.

Halflytely has a total of 1 drug patent out of which 1 drug patent has expired.

Expired drug patents of Halflytely are:

  • US7291324

Halflytely was authorised for market use on 16 July, 2010.

Halflytely is available in for solution, tablet, delayed release;oral dosage forms.

Halflytely can be used as gastrointestinal lavage indicated for cleansing of the colon as a preparation for colonoscopy in adults.

The generics of Halflytely are possible to be released after 22 October, 2022.

Drugs and Companies using BISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE ingredient

Market Authorisation Date: 16 July, 2010

Treatment: Gastrointestinal lavage indicated for cleansing of the colon as a preparation for colonoscopy in adults

Dosage: FOR SOLUTION, TABLET, DELAYED RELEASE;ORAL

More Information on Dosage

HALFLYTELY family patents

Family Patents